
    
      PROTOCOL OUTLINE: Patients are treated with daily olsalazine. The dose is increased each week
      until the protocol dose is reached.

      Supplemental acetaminophen is allowed; nonsteroidal anti-inflammatory drugs continue
      unchanged. Concurrent sulfasalazine is prohibited.
    
  